Marketing approvals for cell and gene therapy products in oncology: Current review of EMA and FDA approvals. Vehicle 1 Doxorubicin HSP90 Inhibitor 1 Doxorubicin+HSP90 Inhibitors 1 Vehicle 2 ...
Drug discovery is often described as searching for a needle in a haystack, with only a tiny number of drug compounds simultaneously safe, effective, and synthesizable. The reality is far more daunting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results